UNSPSC 51282956: Ofloxacin

This classification denotes a quinolone antibiotic with the molecular formula C18H20FN3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) A4P49JAZ9H, chemically known as 86393-32-0 (hydrochloride, monohydrate) but more generally known as ofloxacin, which bears U.S. National Institutes of Health Compound Identifier 2764. European Medicines Agency schedules Ofloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09422MIG.

UNSPSC 51282956 Ofloxacin, a Commodity code, represents antibiotic pharmaceutical products procured by state and local health agencies. The scope of work under this code includes the supply of fluoroquinolone antibiotics and related pharmaceutical inventory for public health programs. State and local issuers soliciting under the code include state departments of public health and county health agencies purchasing pharmaceutical stock for community health initiatives and emergency preparedness. Procurement activity reflects demand for pharmaceutical warehouse orders and bulk supply contracts, typically structured as multi-year agreements with quarterly or as-needed delivery schedules.

Recent activity shows limited direct ofloxacin procurement; the Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392, closed award of $2,999,999.11 over the life of the contract) for ciprofloxacin and doxycycline rather than ofloxacin itself, and Seminole County, Florida issued an IFB (IFB60459723LAS, response deadline July 26, 2023) for naloxone and drug deactivation systems—a different therapeutic class. Recent solicitations in the state and local market under this taxonomy show primary activity in Illinois and Florida, though the opportunities posted do not substantively address ofloxacin procurement specifically. The code sees limited transparent recent activity; vendors pursuing state and local pharmaceutical supply contracts should monitor cooperative purchasing vehicles and state department of health solicitations for actual ofloxacin demand signals.